Literature DB >> 2178215

Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens.

P J Kushner1, E Hort, J Shine, J D Baxter, G L Greene.   

Abstract

To prepare large amounts of the human estrogen receptor (ER) for biochemical and biophysical studies we have employed the cloned ER sequences to construct Chinese hamster ovary (CHO) cell line derivatives that overexpress the receptor. We have employed an efficient expression vector (SV40 enhancer, human metallothionein IIA promoter) and a new system of gene amplification based on the human metallothionein IIA gene and stepwise selection in cadmium. Cells from the initial transfected pools, before gene amplification, had as much or more ER than human MCF7 cells and responded to the subsequent stepwise cadmium selection and amplification with increases in ER levels to about 2 million receptors/cell. Cell lines isolated from these pools are stable for human ER expression and display up to 6 million receptors/cell, or about 0.4% of the total cell protein. The CHO receptor activates a transfected reporter gene in responses to estrogen, is down-regulated in response to estrogens, displays the same electrophoretic mobility as the MCF7 receptor, and is free of degradation as initially extracted. CHO cells displaying 3 million or more human ER/cell (but not cells with lower levels) flatten and stop growing within the first 24 h after exposure to physiological estrogen concentrations. After several days in estrogen the majority of the cells lyse. The antiestrogen 4-hydroxytamoxifen also causes cell death, but another antiestrogen, ICI 164,384, is without toxic effect. The basis for these phenomena are unknown, but mutants isolated for survival of estrogen treatment have lost receptor expression, thereby confirming the role of receptor in cell death.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178215     DOI: 10.1210/mend-4-10-1465

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  23 in total

1.  ER beta inhibits proliferation and invasion of breast cancer cells.

Authors:  G Lazennec; D Bresson; A Lucas; C Chauveau; F Vignon
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

Review 2.  Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues.

Authors:  C S Watson; R A Alyea; Y-J Jeng; M Y Kochukov
Journal:  Mol Cell Endocrinol       Date:  2007-05-21       Impact factor: 4.102

3.  Xenoestrogens are potent activators of nongenomic estrogenic responses.

Authors:  Cheryl S Watson; Nataliya N Bulayeva; Ann L Wozniak; Rebecca A Alyea
Journal:  Steroids       Date:  2006-12-18       Impact factor: 2.668

4.  Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line.

Authors:  Z Q Ma; E Spreafico; G Pollio; S Santagati; E Conti; E Cattaneo; A Maggi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer.

Authors:  Jin Liu; Bryan Welm; Ken M Boucher; Mark T W Ebbert; Philip S Bernard
Journal:  Am J Pathol       Date:  2011-12-02       Impact factor: 4.307

6.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

Review 7.  Proteins of multiple classes may participate in nongenomic steroid actions.

Authors:  Cheryl S Watson; Bahiru Gametchu
Journal:  Exp Biol Med (Maywood)       Date:  2003-12

8.  Functional estrogen receptors in a human preosteoclastic cell line.

Authors:  G Fiorelli; F Gori; M Petilli; A Tanini; S Benvenuti; M Serio; P Bernabei; M L Brandi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6.

Authors:  M J Pilat; J K Christman; S C Brooks
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells.

Authors:  J C Reese; B S Katzenellenbogen
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.